United Therapeutics–Liquidia $380.7 Million Settlement, Payment Schedule, Yutrepia Changes and What Patients Need to Know
United Therapeutics Corporation and Liquidia Corporation have signed a global settlement, dated October 13, 2026, resolving six legal disputes over patents, trade secrets, contract claims and antitrust allegations tied to inhaled treprostinil drugs. The disclosed payments total $380.7 million: a $175 million net payment to United Therapeutics within 30 business days, $145.4 million in two…
